Follow-up research on prognois of autoimmune pancreatitis after tapering steroid
Not Applicable
- Conditions
- autoimmune pancreatitis
- Registration Number
- JPRN-UMIN000003798
- Lead Sponsor
- Department of Gastroenterology, University of Tokyo
- Brief Summary
21 patients with AIp were enrolled. Clinical relapse was observed in 8. Serological relapse without clinical relapse was observed in 5. There was not any relapse in 8.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who need steroid therapy for other diseases than autoimmune pancreatitis 2)Patients with past history of hospitalization due to relapse during maintenance steroid therapy 3) Patients whom doctors in charge judged that the entry is inadequate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of no relapse, clinical relapse, and serological relapse in three years after tapering steroid
- Secondary Outcome Measures
Name Time Method Morphological change of pancreas Pancreatic endocrine function Occurrence of malignancy Survival time